Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 64 Conferences, 8 Workshops and 69 relevant Journals are presently dedicated exclusively to Rosacea Medicine and about 240 articles are being published on Rosacea Medicine.
Rosacea is a common skin condition that causes redness in your face and often produces small, red, pus-filled bumps. Although rosacea can occur in anyone, it most commonly affects middle-aged women who have fair skin.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Rosacea causes skin on the face to redden and can result in acne-like bumps, but it isn’t just an aesthetic problem. Some rosacea patients experience itching, stinging and burning sensations on the affected skin, which can make sleeping, concentrating and social interactions challenging.
Rosacea is a chronic condition characterized by facial erythema (redness) and sometimes pimples. Rosacea affects all ages and has four subtypes, three affecting the skin and the fourth affecting the eyes (ocular type). Left untreated it worsens over time. Treatment in the form of topical steroids can aggravate the condition. It primarily affects people of northwestern European descent and has been nicknamed the 'curse of the Celts' by some in Britain and Ireland, although recently this has been questioned. Rosacea affects both sexes, but is almost three times more common in women. It has a peak age of onset between 30 and 60. Rosacea typically begins as redness on the central face across the cheeks, nose, or forehead, but can also less commonly affect the neck, chest, ears, and scalp. In some cases, additional symptoms, such as semi-permanent redness, telangiectasia (dilation of superficial blood vessels on the face), red domed papules (small bumps) and pustules, red gritty eyes, burning and stinging sensations, and in some advanced cases, a red lobulated nose may develop. Rosacea is a skin disease typically appearing in people during their 30s and 40s. It is marked by redness (erythema) of the face, flushing of the skin, and the presence of hard pimples (papules) or pus-filled pimples (pustules), and small visible spider-like veins called telangiectasias. In later stages of the disease, the face may swell and the nose may take on a bulb-like appearance called rhinophyma. Mild cases are often not treated at all, or are simply covered up with normal cosmetics. Therapy for the treatment of rosacea is not curative, and is best measured in terms of reduction in the amount of erythema and inflammatory lesions, decrease in the number, duration, and intensity of flares, and concomitant symptoms of itching, burning, and tenderness. The two primary modalities of rosacea treatment are topical and oral antibiotic agents. Laser therapy has also been classified as a form of treatment. While medications often produce a temporary remission of redness within a few weeks, the redness typically returns shortly after treatment is suspended. Long-term treatment, usually one to two years, may result in permanent control of the condition for some patients.
Rosacea Medicine Conference provides wide range knowledge of the latest on the diagnosis, prevention, and treatment of dermatologic disease from the foremost experts in the field. And Also Treatment Through Behavior and Madication and Laser. Featured many interesting presentations about ongoing research and new treatment options for a variety of conditions. One of the many conditions discussed during the conference was rosacea, which causes erythema, pimples, pustules and a flushing and blushing phenomenon.1 The condition is classified into four subtypes: erythematotelangiectatic rosacea (facial redness), papulopustular rosacea (bumps and pimples), phymatous rosacea (skin thickening) and ocular rosacea (eye irritation).1 The primary FDA-approved therapies currently used to treat rosacea include 40 mg doxycycline in a rapid-release form, topical metronidazole and topical azelaic acid.
Market Analysis:
The global dermatology devices market is expected to reach $11,337.0 million by 2019 from $6,578.23 million in 2014, at a CAGR of 11.50% between 2014 and 2019. Dermatology devices assist in enhancing and improving the patient’s skin conditions. With the use of dermatological devices such as dermatoscopes, microscopes, and imaging techniques, the dermatologists are able to identify the skin disorders at an early stage. Dermatology treatment devices are widely used for the treatment of various skin indications such as scars, psoriasis, acne, skin cancer, varicose veins, and pigment and vascular lesions. The hair removal application is one of the largest application segments of the global dermatology treatment devices market in 2014.
List of Best International Conference:
Relevant Society and Associations:
Companies:
This page will be updated regularly.
This page was last updated on November 22, 2024
